Skip to main content
Clinical Trials/NCT03581474
NCT03581474
Terminated
Not Applicable

Evaluation of a Bronchoalveolar Lavage Procedure With a Flexible Disposable Bronchoscope, Ambu aScope 3 Large in Patients in an Intensive Care Unit Setting

Ambu A/S1 site in 1 country12 target enrollmentSeptember 28, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atelectasis
Sponsor
Ambu A/S
Enrollment
12
Locations
1
Primary Endpoint
Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL Treatment
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.

Detailed Description

The purpose of this investigation it to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung. The hypothesis is that aScope 3 Large is able to manage the secretion and thereby facilitating the resolution of secretion in the lung.

Registry
clinicaltrials.gov
Start Date
September 28, 2017
End Date
July 3, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ambu A/S
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients ≥18 years
  • Clinical indication and eligible for a BAL procedure, as judged by the investigator
  • Patients being admitted in the ICU at the investigational centre
  • Provision of signed IC by subject, or subject's legal representative e.g. next of kin

Exclusion Criteria

  • Patients where BAL treatment cannot be clinically justified, judged by the investigator
  • ETT \>7 mm and ≤8.5 mm in diameter
  • Participating in other interventional clinical investigations or have previously participated in this investigation

Outcomes

Primary Outcomes

Improvement in Oxygenation (PaO2/FiO2 Ratio) After a BAL Treatment

Time Frame: 4 hours after procedure

Resolution of atelectasis measured by improvement in oxygenation after a bronchoscopic procedure (bronchoalveolar lavage treatment). PaO2/FiO2 ratio will be compared between baseline and 4 hourst post the BAL procedure.

Study Sites (1)

Loading locations...

Similar Trials